Key Highlights

  • Marsh & McLennan reported Q2 2026 adjusted EPS of $2.96, matching consensus estimates exactly.
  • Revenue rose 6% year-over-year to $7.4 billion, with underlying growth of 5%.
  • The company repurchased $750 million in shares during the quarter, bringing year-to-date buybacks to $1.5 billion.
  • Consulting revenue surged 10%, outpacing the 4% growth in risk and insurance services.

The result matched the consensus estimate precisely, a rare alignment that left shares little changed in early trading. Revenue climbed 6% year-over-year to $7.4 billion, while underlying growth, stripping out currency and portfolio moves, reached 5%. The company also accelerated its shareholder returns, repurchasing $750 million in stock during the quarter and raising its dividend by 10%.

Earnings Align With Estimates

Marsh & McLennan’s second-quarter adjusted EPS of $2.96 landed exactly on the consensus mark, a feat that often eludes even the most predictable companies. The figure represented a 9% increase from the prior year, driven by a combination of revenue growth and margin expansion. GAAP earnings per share came in at $2.63, reflecting the impact of intangible amortization and other adjustments.

For the first half of 2026, adjusted EPS rose 8% to $6.25, while GAAP EPS fell to $4.99 from $5.23 a year earlier. The company’s ability to hit estimates dead-on suggests a stable demand environment, though it also leaves little room for upside surprises in the near term.

Revenue Growth Led by Consulting

The company’s top line grew 6% year-over-year to $7.4 billion, with consulting emerging as the standout performer. Consulting revenue jumped 10%, or 8% on an underlying basis, fueled by strong demand for strategy and wealth management services. Mercer, the company’s benefits and investment consulting arm, saw revenue rise 7%, with wealth solutions leading the way at 8% growth.

Meanwhile, risk and insurance services grew a more modest 4%, though Marsh Risk managed a 6% increase, driven by international markets. The mixed performance across segments highlights the company’s diversification but also underscores the uneven recovery in reinsurance markets. Year-to-date, the stock is up just 0.2%, but it has rallied 12.5% over the past month, outpacing the broader market.

The company’s market capitalization stands at $87.7 billion, with shares trading near the middle of their 52-week range of $156.60 to $213.80. The in-line earnings report suggests investors are pricing in steady execution rather than breakout growth, a dynamic that could keep the stock range-bound unless macroeconomic conditions shift. The company’s aggressive share buybacks, $1.5 billion year-to-date, may provide some support, but the real test will be whether consulting growth can sustain its momentum.

Dividend Hike and Buybacks Signal Confidence

Looking ahead, the next immediate catalyst is the company’s third-quarter dividend, which was raised 10% to $0.99 per share and is payable on August 14. The dividend increase, coupled with the accelerated buyback program, signals management’s confidence in the company’s cash flow generation. For the full year, investors will be watching whether Marsh & McLennan can maintain its consulting growth trajectory while stabilizing reinsurance revenue.

The company’s next earnings call, scheduled for later today, may provide further clarity on its outlook for the second half of 2026. With no major surprises in this quarter’s results, the focus will shift to execution and capital allocation in the months ahead. Based on the company’s Q2 2026 results released July 21, 2026.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.